Title of article
Antimicrobial Susceptibility Patterns of lt;i gt;Escherichia coli lt;/i gt; Isolates from Hospitalized Patients with Different Infections in Isfahan, Iran: Impact on Empiric Antibiotic Therapy in Associated Infections
Author/Authors
Mostafavi Esfahani ، Nassereddin Department of Pediatric Infectious Disease - Infectious Diseases and Tropical Medicine Research Center, Child Growth and Development Research Center, Research Institute for Primordial Prevention of non-Communicable Disease - Isfahan University of Medical Sciences , Rostami ، Soodabeh Nosocomial Infection Research Center - Isfahan University of Medical Sciences , Poorshariat ، Shekoufe Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences
From page
1
To page
7
Abstract
Background: Escherichia coliis an important cause of urinary tract, bloodstream, and surgical site infections.Objectives: We investigated the organism s antibiotic susceptibility in hospitalized patients under different clinical conditions. Methods: This prospective study was conducted in three referral hospitals located in Isfahan, Iran. Different clinical samples were tested using standard routine microbiological methods to identify E. coli strains and determine their antibiotic susceptibility patterns by the disk diffusion method according to CLSI recommendations. After conducting a clinical investigation, contaminated samples were excluded, and the hospital or community source and infection site were identified. Data on antibiotic susceptibility testing were extracted using WHONET software. Data analysis was then conducted using SPSS Statistics version 18.0. Results: Of 1248 E. coliisolates, 71.9% were from urine, 15.1% from blood, and 7.8% from skin and soft tissue samples. High susceptibility was observed to Imipenem (98%), Meropenem (98.0%), and Amikacin (94.6%); intermediate sensitivity to Gentamicin (68.6%) and Cefepime (51.9%); and low susceptibility to Ceftazidime (46.8%), Ceftriaxone (41.3%), Ciprofloxacin (39.5%), Cefotaxime (39.3%), and Trimethoprim-sulfamethoxazole (32.4%). Conclusions: Antibiotics, including Imipenem, Meropenem, or Amikacin, would be beneficial in the empiric therapy of severe infections where E. coliis the main cause.
Keywords
E. coli , Microbial Sensitivity Tests , Drug Resistance , Microbial , Iran
Journal title
International Journal of Infection
Journal title
International Journal of Infection
Record number
2766110
Link To Document